A variety of aminoazoles were reacted with bidentate electrophiles producing azolopyrimidines. The regioselectivity of the nucleophilic attack could be defined from the 13 C chemical shift of the pyrimidine carbons and through NOE experiments.
Introduction
Azolopyrimidines are biologically interesting molecules as indicated by the large number of recent papers dealing with synthesis, chemistry, and pharmacology of these molecules [1 -9] . For example, zaleplon (1), a pyrazolopyrimidine, is a hypnotic agent licensed for treatment of insomnia [10] , and allopurine (2), a 4-hydroxypyrazolopyrimidine used in the treatment of hyperuricemia and gout, inhibits de novo purine biosynthesis and xanthine oxidase [11] (Fig. 1) . The triazolopyrimidine trapidil and its derivatives are coronary vasodilating and potential antiatherosclerotic drugs [12 -14] . Also, pyrimidobenzimidazoles have been found to be of pharmacological interest; for example, pyrimido[1,2-a]benzimidazoles have been described as anti-hypertensive [15] , anti-diabetic [16] and anti-inflammatory [17] .
Results and Discussion
Azolopyrimidines with bridgehead nitrogen atoms are usually obtained from the reaction of bidentate electrophiles with cyclic amidines [18 -20] . Because of the aromaticity of the reaction products in a variety of cases, acyclic intermediates for such reactions could not be isolated and structures assigned for reaction products were based mainly on ambiguous considerations. Recently, for example, Elnagdi et al. [21] could show through X-ray crystallography that, in the reaction of 3-aminopyrazole with benzylidenemalononitrile, the exocyclic amino group and not the ring ni-0932-0776 / 08 / 0200-0217 $ 06.00 © 2008 Verlag der Zeitschrift für Naturforschung, Tübingen · http://znaturforsch.com trogen atom, as it was generally accepted [22] , is the prime site of attack.
We now report on the reaction of 3(5)-aminopyrazoles 3a, b, 2-aminobenzimidazole (4), and 3-amino-1,2,4-triazole (5) with arylidenemalononitrile 6, enaminonitrile 7, and β -ketoester 8 to show that the 13 C chemical shifts of pyrimidine carbons and NOE experiments can be utilized to ascertain the regioselectivity of addition or condensation reactions (Fig. 2) .
Compounds 3a, b reacted with arylidenemalononitrile 6 to yield aminopyrazolo- [1,5-a] pyrimidines that may be formulated as 10a, b or isomeric 12a, b. Thus, if the initial addition involves ring nitrogen atom N-2, as has been assumed earlier by Elnagdi et al. [22] , Michael adduct 11 would be formed, which then on cyclization would yield 12. On the other hand, if the exocyclic amino function reacts with the electrophilic carbon atom of 6, 9 would be formed. The latter com- pounds would undergo cyclization and autoxidation to afford 10 (Scheme 1).
The 13 C NMR spectra of the reaction products revealed the pyrimidine carbon atom C-6 at δ ∼ 71 ppm. This can be assigned only to C-6 in compound 10, as in 12 this carbon would be shielded only by the cyano group, while in 10 shielding by both the cyano group and the lone pair of electrons of the amino group leads to such high-field chemical shift. This conclusion is based on analogy to 13 C NMR data of 10 whose structure could be supported by X-ray crystallography [21] .
Similarly, 2-aminobenzimidazole 4 reacted with 6 to yield a pyrimido [1,2-a] benzimidazole that may be formulated as 13 or isomeric 14 (Scheme 2). Structure 13 could be readily established for this product based on its 13 C NMR spectrum, as well as on results of NOE difference experiments. Thus, the 13 C NMR signal of the pyrimidine carbon atom C-3 appeared at δ = 72 ppm, which is consistent with structure 13 in which both amino and cyano groups are shielding. Scheme 2. Moreover, irradiation at the amino group resonance has enhanced the 6-H signal in the pyrimido[1,2-a]benzimidazole ring.
The reaction of 3-amino-1,2,4-triazole 5 with 6 could afford the isomeric products 15 -18 (Scheme 3). bon atom C-6 at δ = 75 ppm, which clearly excludes possible formation of 16 or 18, and we are left with 15 and 17. NOE difference experiments indicated that the triazole proton and the amino protons do not show mutual signal enhancement, thus establishing structure 15 as the reaction product. Thus, it is believed that 3-aminotriazole 5 behaves analogously to 3 and 4; the exocyclic amino function is also the prime site of attack by the electrophilic α,β -unsaturated moiety. Similar to the behavior of 6 toward 3a, 4, and 5, 3-(piperidin-1-yl)acrylonitrile 7 reacted with 3a, 4, and 5 to yield aminoazolopyrimidines 19, 20 and 21, respectively (Fig. 3) . The structure of the latter products was established by 13 (Fig. 4) [23] .
In the course of our investigations, we found that the reaction of 3a and ethyl acetoacetate 8 in acetic acid solution afforded 25 as indicated from NOE experiments showing that the methyl and the 6-H protons are proximal. Similarly, reaction of 4 and 5 with ethyl acetoacetate led to formation of 4-methyl-pyrimido[1,2-a] benzimidazol-2-one (26) and 7-methyl-1,2,4-triazolo [1,5-a]pyrimidin-5-one (27), respectively. The structures of products 26 and 27 were also derived on the basis of NOE experiments (Fig. 5) . Thus, the presence or absence of an NOE between specific protons allowed the structures for these compounds to be established.
Experimental Section

General procedures
All melting points were determined on a GallenKamp electrothermal apparatus and are uncorrected. IR spectra were recorded as KBr pellets with a Pye Unicam SP 3000 infrared spectrophotometer. 1 H and 13 C NMR spectra were recorded in deuterated dimethylsulfoxide [D 6 ]-DMSO solution at 300 MHz on a Varian Gemini NMR spectrometer using tetramethylsilane (TMS) as internal reference, and the results are expressed as δ values. Mass spectra were performed on a Shimadzu GCMS-QP 1000 Ex mass spectrometer at 70 eV. Elemental analyses were carried out at the Microanalytical Center of Cairo University.
General procedure for the preparation of compounds 10a,b, 13 and 15
A mixture of aminoazoles 3a, b, 4 or 5 (0.01 mol) in pyridine (10 mL), and arylidenemalononitrile 6 (0.01 mol) was refluxed for 6 h. The solid product was filtered off and crystallized from dimethylformamide to give compounds 10a,b, 13 and 15, respectively. [1,2-a] benzimidazole (13) [1,5-a] pyrimidine (15) This compound was obtained as colorless crystals, (2. 
7-Amino-6-cyano-5-(4-chlorophenyl)-2-phenyl-pyrazolo [1,5-a]pyrimidine (10a)
7-Amino-6-cyano-5-(4-chlorophenyl)-2-(4-methylphenyl)-pyrazolo[1,5-a]pyrimidine (10b)
4-Amino-3-cyano-2-(4-chlorophenyl)-pyrimido
7-Amino-6-cyano-5-(4-chlorophenyl)-triazolo
General procedure for the preparation of compounds 19, 20 and 21
A solution of 3a, 4 and 5 (0.01 mol) and 7 (1.36 g, 0.01 mol) in pyridine (10 mL) was refluxed for 5 h, then left to cool at r. t. The solid product, formed was collected by filtration and crystallized from dimethylformamide to give compounds 19, 20 and 21, respectively.
7-Amino-2-phenyl-pyrazolo[1,5-a]pyrimidine (19)
This compound was obtained as yellow crystals, (1. [1,5-a] pyrimidine (21) 
7-Amino-triazolo
4-Methyl-pyrimido[1,2-a]benzimidazol-2-one (26)
This compound was obtained as yellow crystals, (1. 
